![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 27, 25359-25365, July 6, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Departments of
Received for publication, April 5, 2001
Gln3p is a GATA-type transcription
activator of nitrogen catabolite repressible (NCR) genes. Gln3p
was recently found to be hyperphosphorylated in a
TOR-dependent manner and resides in the cytoplasm in high
quality nitrogen. In contrast, during nitrogen starvation or rapamycin
treatment, Gln3p becomes rapidly dephosphorylated and accumulates in
the nucleus, thereby activating nitrogen catabolite repression genes.
However, a detailed mechanistic understanding is lacking for the
regulation of Gln3p nucleocytoplasmic distribution. In this study, we
applied a functional genomics approach to identify the nuclear
transport factors for Gln3p. We found that yeast karyopherin In response to nitrogen levels and sources, eukaryotic cells
selectively regulate expression of genes involved in utilization and
transport of the available nutrients. In the presence of rich nitrogen
sources, the expression of genes necessary for utilization and
transport of poor nitrogen sources is repressed. These genes become
derepressed in a poor nitrogen source such as glutamate. This
phenomenon is called nitrogen catabolite repression
(NCR)1 (reviewed in Ref. 1).
Genetic analysis in budding yeast led to the identification of
regulatory pathways that detect the quality of nutrients and regulate
gene expression. A number of GATA-type transcription factors have now
been identified, including Gln3p, Nil1p/Gat1p, and Nil2p/Gzf3p (2-4).
In particular, Gln3p has been the primary focus for most subsequent
studies. It is a transcriptional activator of NCR genes when only poor
nitrogen sources are available or during nitrogen starvation. Ure2p is
a yeast pre-prion protein genetically antagonistic to Gln3p (5,
6).
Recent studies have shed light into the regulatory events leading to
activation of Gln3p. TOR is the yeast target of rapamycin (7-12) and a
key player of nutrient-mediated signal transduction (recently reviewed
in Refs. 13-16). Major NCR transcription factors, including Gln3p,
Nil1p/Gat1p, and Nil2p/Gzf3p interact with both Tor1p and Tor2p (17).
Nitrogen starvation or inhibition of TOR by rapamycin causes rapid
dephosphorylation and nuclear accumulation of Gln3p in vivo
(17, 18) and expression of a wide variety of NCR genes (17, 19-21).
TOR is a protein serine/threonine kinase (22-24) and appears to be
responsible for Gln3p phosphorylation (17) and may also regulate Gln3p
dephosphorylation (17, 18). In addition to the classic NCR
transcription factors, TOR also mediates nitrogen signaling to regulate
Rtg1/3p, transcription factors involved in regulation of several genes
of the trichloroacetic acid cycle (25). Although hyperphosphorylation
of Gln3p correlates well with its cytoplasmic retention and
dephosphorylation is consistent with its nuclear accumulation, it
remains to be determined whether and how phosphorylation directly
influences the nuclear accumulation of Gln3p.
Recent progress has defined the basic mechanism of nuclear transport
(26-28). Nuclear import and export factors interact with distinct
targeting signals and share common functional and structural domains.
These are collectively called karyopherins (also importins/exportins, transportins). Analysis of the Saccharomyces data base
revealed a total of 14 proteins belonging to the karyopherin Cells can respond to extracellular signals by modulating gene
expression, which requires the transfer of information from the plasma
membrane to the nucleus. Protein kinase cascades are commonly involved
in transducing these signals, and they typically culminate in the
phosphorylation of transcription factors. Phosphorylation of both
transcription factors and kinases results in regulation of their
nuclear localization, suggesting that control of the subcellular
localization of these proteins is important for the response to
extracellular signals (reviewed in Refs. 44 and 45). Phosphorylation
can directly regulate the recognition of targeting signals by soluble
karyopherins and effectively modulates nucleocytoplasmic translocation
(reviewed in Refs. 44 and 45). For example, phosphorylation of the
phosphate-regulated transcription factor Pho4p at Ser-152 disrupts its
association with the karyopherin In this study, we found that at least two nuclear transport factors,
karyopherin Yeast Strains and Plasmids--
All of the yeast strains are
shown in Table I. The deletion and
temperature-sensitive mutants for karyopherins have been described previously (40, 48-54). Yeast media and culture conditions are followed according to standard procedures. Rapamycin is dissolved in methanol and stored at
For the plasmid expressing GST-Srp1 (pSW347), oligonucleotides were
used in the polymerase chain reaction to generate the SRP1 open reading
frame flanked by BamHI restriction sites. The fragment was
inserted into BamHI-digested pGEX-3x, such that the coding
sequence for GST was in frame with the second codon of SRP1. To
generate pRS315-GLN3-MYC9 and
pRS416-GLN3-MYC9, the chromosomal gene GLN3-MYC9 and its natural promoter were
generated by polymerase chain reaction from genomic DNA prepared from
the GLN3-MYC9 strain (17) and cloned into pRS315
(LEU CEN) or pRS416 (URA CEN) using the
SalI and NotI restriction sites. The resultant
plasmids were transformed into yeast and shown to express
Gln3p-MYC9 at a level comparable with that of the
chromosomal GLN3-MYC9.
pRS315-GLN3-MYC9 and
pRS416-GLN3-MYC9 were transformed
into wild type and mutant strains and used for both phosphorylation and
indirect immunofluorescence (IF) studies.
Northern Blotting Analysis--
Exponential wild type and mutant
yeast cultures were treated with 200 nM rapamycin. Aliquots
of yeast cultures were withdrawn at different times. Total yeast RNAs
were prepared using the phenol freezing extraction method (55). 20-µg
total yeast RNA samples were separated on denaturing agarose gels,
transferred onto nylon filters, hybridized to 32P-labeled
DNA probes, and detected by phosphorus imaging. For the temperature-
and cold-sensitive mutants, yeast were first grown to the early log
phase, shifted to nonpermissive temperatures for 2-3 h, and then
treated with 200 nM rapamycin.
Western Blotting Analysis, Immunoprecipitation, and Phosphatase
Treatment--
Log phase yeast cells were harvested and lysed with
glass beads in disruption buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% Nonidet P-40 plus a
mixture of protease inhibitors; Roche Molecular Biochemicals) by
vortexing. 1 mg of total protein was used for immunoprecipitation with
5 µg of monoclonal antibody (mAb) 9E10 for MYC. For Western blotting
analysis, 20-µg protein samples were used for gel electrophoresis and
detected by ECL (Amersham Pharmacia Biotech) with mAb 9E10. For the
phosphatase treatment, cell extracts containing Gln3p-MYC9
were incubated with CIP buffer alone, 20 units of CIP (Roche Molecular
Biochemicals), or 20 units CIP plus phosphatase inhibitor 10 mM Na4P2O7 for 10 min
at 30 °C.
Immunofluorescence Microscopy--
The wild type and mutant
yeast strains expressing the Gln3p-MYC9 fusions were used
for indirect IF studies. For the cold- and temperature-sensitive
mutants, the yeast cells were grown to mid-log phase at their
permissive temperatures (30 °C for srp1cs;
23 °C for all other mutants) and then shifted to the nonpermissive temperatures for 2-3 h (20 °C for srp1cs,
35 °C for crm1-1ts, and 37 °C for all
other temperature-sensitive mutants). 200 nM rapamycin was
then added for the duration indicated in each experiment. The IF
studies were carried out as described previously (17) using anti-MYC
monoclonal antibody 9E10, and incubation was continued for an
additional time as indicated for each experiment.
GST Fusion Protein and in Vitro Binding Assays--
Bacteria
were grown at 37 °C in 250 ml of liquid broth medium containing 100 µg/ml ampicillin to an optical density of 0.4 and were induced with 1 mM isopropyl-1-thio- Rapamycin treatment or nitrogen starvation leads to nuclear
accumulation of Gln3p and activation of Gln3p-dependent
genes such as GAP1 (general amino
acid permease 1) (17, 18). We reasoned that mutations in the Gln3p import factor would prevent Gln3p
from accumulating in the nucleus in the presence of rapamycin. Under
such conditions, there would be no expression of GAP1. In contrast, dysfunction of the export pathway would cause constitutive nuclear accumulation of Gln3p and a high level of GAP1
expression in the absence of rapamycin. Therefore, GAP1 can
be conveniently used as a reporter to monitor the import/export of
Gln3p by examining the effect of their mutations on GAP1
expression (Fig. 1a). There are a total of 14 karyopherin We have screened all the yeast karyopherin mutants using Northern blot
analysis for GAP1. As expected, GAP1 expression
patterns in a majority of the karyopherin mutants were similar to the
wild type strain; GAP1 expression was essentially
undetectable in the absence of rapamycin but increased significantly in
the presence of rapamycin (Fig. 1b). However,
GAP1 expression remained very low or undetectable both in
the presence and in the absence of rapamycin in two mutant strains,
srp1cs and cse1-1cs (Fig.
1b). Both srp1cs and
cse1-1cs are cold-sensitive mutants. The
induction of GAP1 by rapamycin was normal at the permissive
temperature (30 °C) (data not shown) but not at the nonpermissive
temperature (20 °C) (Fig. 1b). Cse1p is a karyopherin
required for the export of Srp1p from the nucleus to the cytoplasm (57,
58). The cse1-1cs mutation may affect
GAP1 expression indirectly by preventing the return of Srp1p
to the cytoplasm. Kap95p is a co-factor for karyopherin- To confirm the above findings, we directly examined the effects of
srp1cs and crm1-1ts
mutations on the localization of Gln3p by indirect immunofluorescence. In agreement, we found that Gln3p remained in the cytoplasm in the
absence and the presence of rapamycin in the
srp1cs mutant at the nonpermissive temperature
(20 °C) in high quality nitrogen (Fig.
2a). In contrast, Gln3p
localization was normal at the permissive temperature (30 °C) (Fig.
2a). We also showed that Gln3p was exclusively localized to
the nucleus both in the absence and the presence of rapamycin in the
crm1-1ts mutant at 35 °C (Fig.
2b). Taken together, our data indicate that Srp1p and Crm1p
are the karyopherins that mediate Gln3p nuclear entry and exit. Under
physiological conditions, nitrogen sources and levels control Gln3p
localization. To further establish the role of Srp1p in nitrogen signal
transduction, we examined Gln3p localization in the
srp1cs mutant strain under different nitrogen
conditions (Fig. 3). We found that Gln3p
was primarily located in the cytoplasm in rich nitrogen but rapidly
accumulated in the nucleus during nitrogen starvation in the wild type
strain at both 30 °C and 20 °C and in the
srp1cs mutant strain at 30 °C (permissive
temperature). In contrast, Gln3p remained in the cytoplasm under
nitrogen starvation in the srp1cs mutant strain
at the nonpermissive temperature (20 °C). Therefore, Srp1p is
required for the regulated Gln3p localization by nitrogen conditions.
Phosphorylation Regulates the Interaction between
Gln3p and the Nuclear Import Factor Srp1p*
,
,
¶
Pathology and Immunology and
§ Cell Biology and Physiology, Washington University School
of Medicine, St. Louis, Missouri 63110
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
/Srp1p
and Crm1p are required for the nuclear import and export of Gln3p,
respectively. Similarly, the Ran GTPase pathway is also involved in the
nuclear translocation of Gln3p. Finally, we show that Srp1p
preferentially interacts with the hypophosphorylated versus
the hyperphosphorylated Gln3p. These findings define a possible
mechanism for regulated nucleocytoplasmic transport of Gln3p by
phosphorylation in vivo.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
family, defined partly by a ~150-amino acid region required for
binding to the small GTPase Ran (29, 30). Some of these karyopherin family members have been shown to serve as receptors for the import and/or export of diverse cargo molecules such as proteins and tRNA
(reviewed in Ref. 31). Each karyopherin is likely specific for a
distinct targeting signal. The classical nuclear targeting signal is
typified by the SV40 large T antigen nuclear localization signal (NLS)
that is rich in basic amino acids (32, 33). The import factor
recognizing this NLS is a heterodimer of karyopherin
and
karyopherin
(also termed importins) (extensively reviewed in Refs.
26, 31, and 34). In the cytoplasm, karyopherin
serves as an adaptor
to directly bind the NLS, whereas karyopherin
binds to karyopherin
. The complex then docks at the nuclear pore, translocates across
the pore, and is disassembled in the nucleus. In contrast to the NLS, a
major nuclear export signal is characterized by a small leucine-rich
sequence that is bound by the export factor Crm1/Xpo1 (also called
exportin) and Ran-GTP in the nucleus (35-40). This complex
translocates across the nuclear pore and is disassembled in the
cytoplasm. The small GTPase Ran is thought to impose directionality to
transport processes because its regulators are specifically
compartmentalized within the cell (reviewed in Refs. 26 and 34).
Ran-GTP concentration is presumably high in the nucleus, whereas
Ran-GDP predominates in the cytoplasm. Ran-GTP binds to the karyopherin
family members to facilitate release of import factors from their
cargo in the nucleus (41-43) or to mediate the formation of export
complexes consisting of the export receptor, cargo, and Ran-GTP
(recently reviewed in Ref. 31).
Pse1p and inhibits its nuclear
import (46, 47).
/Srp1p and Crm1p/Xpo1p, are required for the import and
export of Gln3p, respectively. Mutation in Srp1p blocked the nuclear
import of Gln3p and the expression of the Gln3p-dependent
gene GAP1 by rapamycin treatment or nitrogen starvation. In
contrast, shifting to the nonpermissive growth temperature in the
crm1-1ts mutant was sufficient to cause nuclear
accumulation of Gln3p and expression of GAP1 in high quality
nitrogen and in the absence of rapamycin. Furthermore, bacterially
produced karyopherin
/Srp1p binds preferentially to the
hypophosphorylated form of Gln3p. Our results indicate that Gln3p is
dynamically shuttling between the cytoplasm and the nucleus.
TOR-dependent phosphorylation appears to inhibit the
ability of Gln3p to enter into the nucleus by reducing its affinity for
the karyopherin
/Srp1p.
![]()
MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
20 °C. The concentration of rapamycin used throughout this study is 200 nM.
Yeast strains used in this study
-D-galactopyranoside for
3 h. The culture was chilled on ice for 10 min, and the cells were
pelleted and resuspended in 15 ml of lysis buffer (1×
phosphate-buffered saline, 1 mM phenylmethylsulfonyl
fluoride, 1 mM EDTA, 1× protease inhibitor mixture, and 5 mM
-mercaptoethanol). The suspension was subjected to
two freeze-thaw cycles, and the cells were finally disrupted by
sonication. The cell lysate was clarified by centrifugation for 20 min
at 20,000 × g at 4 °C. The recombinant proteins
were purified by glutathione-Sepharose. The in vitro binding
assays for the recombinant proteins were carried out as described
previously (17).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
s and one karyopherin
in the Saccharomyces cerevisiae genome as revealed by genomic
sequence analysis (30, 56). Therefore, we devised a functional genomics approach to identify the factors that affect Gln3p nuclear transport by
monitoring the expression of GAP1 in individual karyopherin mutants in the presence or the absence of rapamycin.

View larger version (42K):
[in a new window]
Fig. 1.
Mutations in SRP1 and
CRM1 yeast karyopherin genes alter GAP1
expression. a, the functional genomics strategy
to identify Gln3p nuclear transport factors. b, exponential
wild type and yeast karyopherin mutant cells were treated with 200 nM rapamycin for 30 min. Total RNA was prepared and
analyzed by Northern blotting with 32P-labeled
GAP1 or ACT1 probes. For the temperature- and
cold-sensitive strains, log phase yeast cultures were shifted to
nonpermissive temperature for 2 h before treatment with 200 nM rapamycin for 30 min. Arrow,
srp1cs and cse1-1cs
mutations completely abolished GAP1 expression when cells
were treated with rapamycin. Double arrow, GAP1
expression remained at a high level in crm1-1ts
even in the absence of rapamycin.
/Srp1p.
Therefore, a loss-of-function mutation in KAP95 was also
expected to inhibit GAP1 expression in the presence of
rapamycin. Unfortunately, the two kap95 mutants we analyzed grew extremely poorly, which precluded us from obtaining good quality
RNA from these strains to address this point. Taken together, the
srp1 and cse1 phenotypes suggest that Srp1p
mediates Gln3p import. In contrast, crm1-1ts, a
temperature-sensitive mutation of CRM1, a known exporting factor, led to a high level of GAP1 expression even in the
absence of rapamycin in high quality nitrogen at the restrictive
temperature (35 °C) (Fig. 1b) but not at the permissive
temperature (25 °C) (data not shown). Thus, Crm1p appears to be the
karyopherin responsible for Gln3p nuclear export.

View larger version (49K):
[in a new window]
Fig. 2.
Srp1p and Crm1p are required for the nuclear
import and export of Gln3p, respectively. a, Gln3p is
constitutively cytoplasmic in the absence or the presence of rapamycin
in the srp1cs mutant. Exponentially growing wild
type (WT) and srp1cs mutant cells
expressing Gln3p-MYC9 were shifted to nonpermissive
temperature (20 °C) for 2 h and then treated with 200 nM rapamycin for 30 min. The localization of
Gln3p-MYC9 was examined by indirect immunofluorescence
staining with mAb 9E10. Yeast nuclei were stained with DAPI.
b, Gln3p accumulates in the nucleus of
crm1-1ts arrested cells. Exponentially growing
wild type and crm1-1ts mutant yeast cells
expressing Gln3p-MYC9 were shifted to nonpermissive
temperature (35 °C) for 2 h and then treated with 200 nM rapamycin for 30 min. The localization of
Gln3p-MYC9 was examined by indirect IF staining with mAb
9E10. The nucleus was stained with DAPI.

View larger version (55K):
[in a new window]
Fig. 3.
Nuclear accumulation of Gln3p during nitrogen
starvation requires a functional karyopherin
/Srp1p.
Exponentially growing wild type (WT) and
srp1cs mutant cells expressing
Gln3p-MYC9 were shifted to nonpermissive temperature
(20 °C) for 2 h and then switched to synthetic complete
(+N) medium or synthetic complete medium without nitrogen
sources (
N) for 30 min. The localization of
Gln3p-MYC9 was examined by indirect immunofluorescence
staining with mAb 9E10. Yeast nuclei were stained with DAPI.
The small GTPase Ran/Gsp1p plays an essential role in nucleocytoplasmic
transport (56, 59). The RanGTP gradient is maintained by two proteins:
RanGAP/Rna1p, which is located in the cytoplasm (60-64), and
RanGEF/Prp20p, which is exclusively found in the nucleus (65).
Disruption of this gradient results in failure of nucleocytoplasmic transport. To determine whether Gln3p transport involves the RanGTP gradient, we investigated the effect of a temperature-sensitive mutation in RanGAP (rna1-1ts) on the expression
of GAP1 and the localization of Gln3p in the absence and the
presence of rapamycin. We found that this mutation completely abolished
the expression of GAP1 (Fig.
4a) and the nuclear import of
Gln3p in the presence of rapamycin at the restrictive temperature
(37 °C) (Fig. 4b). Therefore, the RanGTP gradient is
critical for Gln3p import. This is consistent with the requirement for
Srp1, an adaptor that binds to a Ran-GTP binding karyopherin-
(Kap95).
|
Karyopherin
s are known to directly bind either to their cargo
proteins or to an adaptor. To establish that Srp1p is an adaptor for
Gln3p import and to understand the mechanism of regulated nuclear
import of Gln3p, we investigated possible protein-protein interactions
between Srp1p and Gln3p. We prepared extracts from log phase yeast
cells in high quality nitrogen-containing medium. Under such yeast
growth condition, Gln3p was present predominantly as
hyperphosphorylated forms (Fig.
5a, lane 1,
arrow, and Ref. 17). However, there was still a residual
amount of Gln3p in the dephosphorylated form (Fig. 5a,
lane 1, double arrow, and Ref. 17). This is
consistent with the observation that a small amount of Gln3p is present
in the nucleus even when yeast are grown in the nutrient-rich medium,
presumably because of the need of limited Gln3p molecules for the basal
expression of Gln3p-dependent genes (17). We incubated the
yeast extracts with bacterially produced, affinity-purified GST on
glutathione-Sepharose beads or GST-Srp1p on glutathione-Sepharose
beads. We found that Gln3p specifically bound to GST-Srp1p but not to
GST alone (Fig. 5a). More interestingly, GST-Srp1p only
bound to the dephosphorylated but not the hyperphosphorylated Gln3p
(Fig. 5a). In this experiment, the same amount of GST-Srp1p
was used in each sample as indicated by Coomassie Blue staining (Fig.
5b).
|
To directly demonstrate that phosphorylation regulates the interaction
between Gln3p and Srp1p, we treated the cell extracts with CIP. CIP
resulted in dephosphorylation of Gln3p as indicated by the increase of
its gel mobility (Fig. 6a,
lane 2, and Ref. 17). This dephosphorylation was completely
blocked by Na4P2O7, a potent
phosphatase inhibitor. We found that GST-Srp1p indeed preferentially
bound to the dephosphorylated Gln3p (Fig. 6a, lanes 4-6). The small amounts of hypophosphorylated and
dephosphorylated Gln3p in the CIP-untreated or
CIP/Na4P2O7 sample were barely
detectable (because of the short exposure of the Western blot). The
same amount of GST-Srp1p was used for each different sample as
indicated by Coomassie Blue staining (Fig. 6b). Taken
together, these results show that Gln3p binds to karyopherin
/Srp1p
and that phosphorylation of Gln3p inhibits this interaction.
|
| |
DISCUSSION |
|---|
|
|
|---|
Cellular responses to nitrogen availability and the quality of nitrogen nutrients require regulated nuclear transport of the GATA-type transcription factor Gln3p. Gln3p is phosphorylated in a TOR-dependent manner and localizes predominantly to the cytoplasm when yeast are grown in high quality nitrogen-containing medium. In contrast, Gln3 becomes dephosphorylated and accumulates in the nucleus when yeast are grown in poor nitrogen, grown under nitrogen starvation conditions, or treated with rapamycin (17, 18). In this study, we sought to understand how phosphorylation of Gln3p regulates its nucleocytoplasmic transport and the nuclear transport machinery that moves Gln3p into and out of the nucleus. We found that the srp1cs mutation specifically blocked the nuclear import of Gln3p at nonpermissive temperatures in the presence of rapamycin. In addition, Gln3p binds specifically to bacterially expressed GST-Srp1p in vitro. Taken together, these results indicate that Srp1p is the nuclear import factor for Gln3p.
Crm1p is required for the nuclear export of many proteins, including Hog1p (51), the HIV1 Rev protein (38), Dbp5p (66), and Yap1p (67, 68). We found that the crm1-1ts mutation caused constitutive nuclear retention of Gln3p at the restrictive temperature in high quality nitrogen in the absence of rapamycin (Fig. 2b). Consequently, there was a high expression level of GAP1 under such conditions (Fig. 1). Many Crm1p substrates contain a leucine-rich nuclear export sequence (L-X2-3-(F/I/L/V/M)-X2-3-L-X-(L/I)) (36-40, 69). Interestingly, Gln3p also contains a motif (335LHGTMRPLSL) characteristic of a leucine-rich nuclear export signal. Deletion of this leucine-rich sequence causes nuclear accumulation of Gln3p in nitrogen-rich medium and constitutive expression of GAP1.2 Taken together, our results indicate that Crm1p is the nuclear export factor for Gln3p. A defect in nuclear export as a result of the crm1-1ts mutation is sufficient to cause nuclear accumulation of Gln3p in nitrogen-rich medium, suggesting that a small amount of Gln3p shuttles between the cytoplasm and the nucleus when yeast are grown in nitrogen-rich medium. This observation is also consistent with the presence of a small amount of dephosphorylated Gln3p in the same conditions (Fig. 5a).
Phosphorylation is broadly involved in the regulated transport of many
important proteins between the cytoplasm and nucleus (reviewed in Refs.
44 and 45). Phosphorylation within or adjacent to the NLS sequence can
dramatically affect recognition of cargo proteins by the karyopherins.
One such example is Pho4p, a phosphate-regulated transcription factor.
Pho4p is phosphorylated and localized in the cytoplasm when yeast is
grown in phosphate-rich medium, whereas in low phosphate medium, Pho4p
is dephosphorylated and localized to the nucleus. Pho4p nuclear
translocation requires the karyopherin Pse1. Phosphorylation decreases
the affinity of Pho4p for Pse1p and results in the cytoplasmic
retention of Pho4p (46, 47). A similar scenario may also be true for
Gln3p and possibly other NCR-sensitive transcription activators and
repressors (a model is shown in Fig. 7).
During nitrogen starvation or rapamycin treatment, TOR-dependent phosphorylation decreases, which is possibly
accompanied by an increase in the phosphatase activity toward Gln3p
(17, 18). As a result, the dephosphorylated form of Gln3p predominates and is imported into the nucleus as a result of its interaction with
Srp1p. Our results provide further support for a common mechanism by
which nutrient-sensing transcription factors are controlled by
phosphorylation-dependent interaction with the nuclear
transport machinery.
|
| |
ACKNOWLEDGEMENTS |
|---|
We are grateful to A. Hopper, A. Tartakoff, K. Weis, L. Davis, M. Fitzgerald-Hayes, M. Johnston, and P. Silver for strains, K. Mishra for construction of pSW347, and D. Dean for use of the fluorescence microscopes. We also thank other members of the Zheng laboratory for insightful discussions.
| |
FOOTNOTES |
|---|
* This work was supported by grants from the National Institutes of Health (to S. R. W. and X. F. S. Z.) and by a Howard Hughes Medical Institute New Investigator Award (to X. F. S. Z.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ To whom correspondence should be addressed: Campus Box 8069, 1030 CSRBNT, Washington University School of Medicine, 660 South Euclid Ave., St. Louis, MO 63110. E-mail: zheng@pathology.wustl.edu.
Published, JBC Papers in Press, April 30, 2001, DOI 10.1074/jbc.M103050200
2 J. Carvalho and X. F. S. Zheng, unpublished data.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: NCR, nitrogen catabolite repression; NLS, nuclear localization signal; GST, glutathione S-transferase; IF, immunofluorescence; mAb, monoclonal antibody; CIP, calf intestine alkaline phosphatase; HIV1, human immunodeficiency virus, type 1; DAPI, 4',6-diamidino-2-phenylindole, dialactate.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Magasanik, B. (1992) The Molecular and Cellular Biology of Yeast Saccharomyces , Vol. 2 , pp. 283-318, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY |
| 2. | Courchesne, W. E., and Magasanik, B. (1988) J. Bacteriol. 170, 708-713 |
| 3. | Coffman, J. A., Rai, R., Cunningham, T., Svetlov, V., and Cooper, T. G. (1996) Mol. Cell. Biol. 16, 847-858 |
| 4. | Stanbrough, M., Rowen, D. W., and Magasanik, B. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 9450-9454 |
| 5. | Coschigano, P. W., and Magasanik, B. (1991) Mol. Cell. Biol. 11, 822-832 |
| 6. | Wickner, R. B. (1994) Science 264, 566-569 |
| 7. | Heitman, J., Movva, N. R., and Hall, M. N. (1991) Science 253, 905-909 |
| 8. | Kunz, J., Henriquez, R., Schneider, U., Deuter-Reinhard, M., Movva, N. R., and Hall, M. N. (1993) Cell 73, 585-596 |
| 9. | Cafferkey, R., McLaughlin, M. M., Young, P. R., Johnson, R. K., and Livi, G. P. (1994) Gene (Amst.) 141, 133-136 |
| 10. | Stan, R., McLaughlin, M. M., Cafferkey, R., Johnson, R. K., Rosenberg, M., and Livi, G. P. (1994) J. Biol. Chem. 269, 32027-32030 |
| 11. | Zheng, X. F., Florentino, D., Chen, J., Crabtree, G. R., and Schreiber, S. L. (1995) Cell 82, 121-130 |
| 12. | Lorenz, M. C., and Heitman, J. (1995) J. Biol. Chem. 270, 27531-27537 |
| 13. | Dennis, P. B., Fumagalli, S., and Thomas, G. (1999) Curr. Opin. Genet. Dev. 9, 49-54 |
| 14. | Kuruvilla, F., and Schreiber, S. L. (1999) Chem. Biol. 6, R129-R136 |
| 15. | Schmelzle, T., and Hall, M. N. (2000) Cell 103, 253-262 |
| 16. | Rohde, J., Heitman, J., and Cardenas, M. (2001) J. Biol. Chem. 276, 7027-7036 |
| 17. | Bertram, P. G., Choi, J., Carvalho, J., Ai, W. D., Zeng, C. B., Chan, T. F., and Zheng, X. F. S. (2000) J. Biol. Chem. 275, 35727-35733 |
| 18. | Beck, T., and Hall, M. N. (1999) Nature 402, 689-692 |
| 19. | Cardenas, M., Cutler, N., Lorenz, M., Di Como, C., and Heitman, J. (1999) Genes Dev. 13, 3271-3279 |
| 20. | Hardwick, J. S., Kuruvilla, F., Tong, J. K., Shamji, A. F., and Schreiber, S. L. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 14866-14870 |
| 21. | Shamji, A., Kuruvilla, F., and Schreiber, S. (2000) Curr. Biol. 10, 1574-1581 |
| 22. | Bertram, P. G., Zeng, C., Thorson, J., Shaw, A. S., and Zheng, X. F. (1998) Curr. Biol. 8, 1259-1267 |
| 23. | Jiang, Y., and Broach, J. R. (1999) EMBO J. 18, 2782-2792 |
| 24. | Alarcon, C. M., Heitman, J., and Cardenas, M. E. (1999) Mol. Biol. Cell 10, 2531-2546 |
| 25. | Komeili, A., Wedaman, K. P., O'Shea, E. K., and Powers, T. (2000) J. Cell Biol. 151, 863-878 |
| 26. | Corbett, A. H., and Silver, P. A. (1997) Microbiol. Mol. Biol. Rev. 61, 193-211 |
| 27. | Nakielny, S., and Dreyfuss, G. (1999) Cell 99, 677-690 |
| 28. | Wente, S. R. (2000) Science 288, 1374-1377 |
| 29. | Gorlich, D. (1997) Curr. Opin. Cell Biol. 9, 412-419 |
| 30. | Pemberton, L. F., Blobel, G., and Rosenblum, J. S. (1998) Curr. Opin. Cell Biol. 10, 392-399 |
| 31. | Gorlich, D., and Kutay, U. (1999) Annu. Rev. Cell Dev. Biol. 15, 607-660 |
| 32. | Kalderon, D., Roberts, B. L., Richardson, W. D., and Smith, A. E. (1984) Cell 39, 499-509 |
| 33. | Lanford, R. E., and Butel, J. S. (1985) Virology 147, 72-80 |
| 34. | Mattaj, I. W., and Englmeier, L. (1998) Annu. Rev. Biochem. 67, 265-306 |
| 35. | Fornerod, M., Ohno, M., Yoshida, M., and Mattaj, I. W. (1997) Cell 90, 1051-1060 |
| 36. | Fukuda, M., Asano, S., Nakamura, T., Adachi, M., Yoshida, M., Yanagida, M., and Nishida, E. (1997) Nature 390, 308-311 |
| 37. | Kudo, N., Khochbin, S., Nishi, K., Kitano, K., Yanagida, M., Yoshida, M., and Horinouchi, S. (1997) J. Biol. Chem. 272, 29742-29751 |
| 38. | Neville, M., Stutz, F., Lee, L., Davis, L. I., and Rosbash, M. (1997) Curr. Biol. 7, 767-775 |
| 39. | Ossareh-Nazari, B., Bachelerie, F., and Dargemont, C. (1997) Science 278, 141-144 |
| 40. | Stade, K., Ford, C. S., Guthrie, C., and Weis, K. (1997) Cell 90, 1041-1050 |
| 41. | Gorlich, D., Pante, N., Kutay, U., Aebi, U., and Bischoff, F. R. (1996) EMBO J. 15, 5584-5594 |
| 42. | Chi, N. C., Adam, E. J., Visser, G. D., and Adam, S. A. (1996) J. Cell Biol. 135, 559-569 |
| 43. | Rexach, M., and Blobel, G. (1995) Cell 83, 683-692 |
| 44. | Hood, J. K., and Silver, P. A. (1999) Curr. Opin. Cell Biol. 11, 241-247 |
| 45. | Komeili, A., and O'Shea, E. K. (2000) Curr. Opin. Cell Biol. 12, 355-360 |
| 46. | Kaffman, A., Rank, N. M., and O'Shea, E. K. (1998) Genes Dev. 12, 2673-2683 |
| 47. | Komeili, A., and O'Shea, E. K. (1999) Science 284, 977-980 |
| 48. | Belanger, K. D., Kenna, M. A., Wei, S., and Davis, L. I. (1994) J. Cell Biol. 126, 619-630 |
| 49. | Traglia, H. M., Atkinson, N. S., and Hopper, A. K. (1989) Mol. Cell. Biol. 9, 2989-2999 |
| 50. | Seedorf, M., and Silver, P. A. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 8590-8595 |
| 51. | Ferrigno, P., Posas, F., Koepp, D., Saito, H., and Silver, P. A. (1998) EMBO J. 17, 5606-5614 |
| 52. | DeVit, M. J., and Johnston, M. (1999) Curr. Biol. 9, 1231-1241 |
| 53. | Xiao, Z., McGrew, J. T., Schroeder, A. J., and Fitzgerald-Hayes, M. (1993) Mol. Cell. Biol. 13, 4691-4702 |
| 54. | Kadowaki, T., Chen, S., Hitomi, M., Jacobs, E., Kumagai, C., Liang, S., Schneiter, R., Singleton, D., Wisniewska, J., and Tartakoff, A. M. (1994) J. Cell Biol. 126, 649-659 |
| 55. | Schmitt, M. E., Brown, T. A., and Trumpower, B. L. (1990) Nucleic Acids Res. 18, 3091-3092 |
| 56. | Gorlich, D., Dabrowski, M., Bischoff, F. R., Kutay, U., Bork, P., Hartmann, E., Prehn, S., and Izaurralde, E. (1997) J. Cell Biol. 138, 65-80 |
| 57. | Kutay, U., Bischoff, F. R., Kostka, S., Kraft, R., and Gorlich, D. (1997) Cell 90, 1061-1071 |
| 58. | Hood, J. K., and Silver, P. A. (1998) J. Biol. Chem. 273, 35142-35146 |
| 59. | Izaurralde, E., Kutay, U., von Kobbe, C., Mattaj, I. W., and Gorlich, D. (1997) EMBO J. 16, 6535-6547 |
| 60. | Bischoff, F., Klebe, C., Kretschmer, J., Wittinghofer, A., and Ponstingl, H. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 2587-2591 |
| 61. | Hopper, A., Traglia, H., and Dunst, R. (1990) J. Cell Biol. 111, 309-321 |
| 62. | Mahajan, R., Delphin, C., Guan, T., Gerace, L., and Melchior, F. (1997) Cell 88, 97-107 |
| 63. | Matunis, M., Coutavas, E., and Blobel, G. (1996) J. Cell Biol. 135, 1457-1470 |
| 64. | Melchior, F., Weber, K., and Gerke, V. (1993) Mol. Biol. Cell 4, 569-581 |
| 65. | Bischoff, F. R., and Ponstingl, H. (1991) Nature 354, 80-82 |
| 66. | Hodge, C. A., Colot, H. V., Stafford, P., and Cole, C. N. (1999) EMBO J. 18, 5778-5788 |
| 67. | Yan, C., Lee, L. H., and Davis, L. I. (1998) EMBO J. 17, 7416-7429 |
| 68. | Kuge, S., Toda, T., Iizuka, N., and Nomoto, A. (1998) Genes Cells 3, 521-532 |
| 69. | Fornerod, M., van Deursen, J., van Baal, S., Reynolds, A., Davis, D., Murti, K. G., Fransen, J., and Grosveld, G. (1997) EMBO J. 16, 807-816 |
This article has been cited by other articles:
![]() |
K. H. Wong, M. J. Hynes, and M. A. Davis Recent Advances in Nitrogen Regulation: a Comparison between Saccharomyces cerevisiae and Filamentous Fungi Eukaryot. Cell, June 1, 2008; 7(6): 917 - 925. [Full Text] [PDF] |
||||
![]() |
S. Teichert, M. Wottawa, B. Schonig, and B. Tudzynski Role of the Fusarium fujikuroi TOR Kinase in Nitrogen Regulation and Secondary Metabolism. Eukaryot. Cell, October 1, 2006; 5(10): 1807 - 1819. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Boczko, T. G. Cooper, T. Gedeon, K. Mischaikow, D. G. Murdock, S. Pratap, and K. S. Wells Structure theorems and the dynamics of nitrogen catabolite repression in yeast PNAS, April 19, 2005; 102(16): 5647 - 5652. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Crespo, S. B. Helliwell, C. Wiederkehr, P. Demougin, B. Fowler, M. Primig, and M. N. Hall NPR1 Kinase and RSP5-BUL1/2 Ubiquitin Ligase Control GLN3-dependent Transcription in Saccharomyces cerevisiae J. Biol. Chem., September 3, 2004; 279(36): 37512 - 37517. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. H. Cox, J. J. Tate, and T. G. Cooper Actin Cytoskeleton Is Required For Nuclear Accumulation of Gln3 in Response to Nitrogen Limitation but Not Rapamycin Treatment in Saccharomyces cerevisiae J. Biol. Chem., April 30, 2004; 279(18): 19294 - 19301. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. H. Cox, A. Kulkarni, J. J. Tate, and T. G. Cooper Gln3 Phosphorylation and Intracellular Localization in Nutrient Limitation and Starvation Differ from Those Generated by Rapamycin Inhibition of Tor1/2 in Saccharomyces cerevisiae J. Biol. Chem., March 12, 2004; 279(11): 10270 - 10278. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Carvalho and X. F. S. Zheng Domains of Gln3p Interacting with Karyopherins, Ure2p, and the Target of Rapamycin Protein J. Biol. Chem., May 2, 2003; 278(19): 16878 - 16886. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Nagai, S. Nogami, F. Kumagai-Sano, and Y. Ohya Karyopherin-Mediated Nuclear Import of the Homing Endonuclease VMA1-Derived Endonuclease Is Required for Self-Propagation of the Coding Region Mol. Cell. Biol., March 1, 2003; 23(5): 1726 - 1736. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Crespo and M. N. Hall Elucidating TOR Signaling and Rapamycin Action: Lessons from Saccharomyces cerevisiae Microbiol. Mol. Biol. Rev., December 1, 2002; 66(4): 579 - 591. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. H. Cox, J. J. Tate, and T. G. Cooper Cytoplasmic Compartmentation of Gln3 during Nitrogen Catabolite Repression and the Mechanism of Its Nuclear Localization during Carbon Starvation in Saccharomyces cerevisiae J. Biol. Chem., September 27, 2002; 277(40): 37559 - 37566. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. G. Bertram, J. H. Choi, J. Carvalho, T.-F. Chan, W. Ai, and X. F. S. Zheng Convergence of TOR-Nitrogen and Snf1-Glucose Signaling Pathways onto Gln3 Mol. Cell. Biol., February 15, 2002; 22(4): 1246 - 1252. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||